by Eriksen Insurance | Jul 17, 2026 | Uncategorized
The Affordable Care Act Marketplaces are undergoing significant shifts that are reshaping the landscape for millions of enrollees. Recent developments paint a complex picture of rising costs, enrollment losses, and a fundamental transformation in how people access...
by Eriksen Insurance | Jun 24, 2026 | Uncategorized
Alternative health plan designs are moving from niche to mainstream. For decades, employers managed healthcare costs with the same tools: higher deductibles, narrower networks, and increased cost sharing. A more meaningful shift is now gaining momentum. According to...
by Eriksen Insurance | Jun 12, 2026 | Uncategorized
Commercial healthcare costs are on track to rise 9% in 2027, according to a new analysis from PwC. That would be the highest medical cost trend in nearly two decades. The individual market is projected to increase 8.5%. PwC also revised its 2026 estimates upward,...
by Eriksen Insurance | Jun 12, 2026 | Uncategorized
Novo Nordisk launched an oral version of its weight loss drug Wegovy on January 5, 2026, and the numbers since then have been hard to ignore. In roughly five months, the pill crossed 3 million prescriptions in the U.S., a pace the company describes as one of the...
by Eriksen Insurance | Jun 1, 2026 | Uncategorized
Karleigh McClain did everything she thought she was supposed to do. She researched her options, signed up with a reputable-seeming telehealth company, met virtually with a provider, and started a weight loss medication that had helped her lose 50 pounds just a few...
by Eriksen Insurance | May 15, 2026 | Uncategorized
For the first time in its history, Medicare is preparing to cover weight loss drugs at scale. Beginning July 1, 2026, the new Medicare GLP-1 Bridge will give eligible Part D beneficiaries access to medications like Wegovy, Zepbound, and the newly approved Foundayo for...
